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Introduction
Harmful algal blooms occur when phyto-
plankton accumulate and negatively affect the 
environment and human or animal health. 
Harmful blooms are associated with a small 
subset of phytoplankton species. Out of 
4,000 marine phytoplankton, it is estimated 
that some 200 are high biomass producers, 
and only ~80 are potential toxin-producers 
(Masó and Garcés 2006; Smayda 1997; 
Smayda and Reynolds 2003; Zingone and 
Enevoldsen 2000). Although naturally occur-
ring in fresh, estuarine, and marine waters, 
the growth, toxicity, and geographic distri-
bution of harmful algae have increased in 
part because of environmental factors such 
as nutrient enrichment and warmer water 
temperatures (Dyble et al. 2008; Moore et al. 
2008; Paerl et al. 2001; Paerl and Huisman 
2008, 2009; Sellner et al. 2003). Most epide-
miologic studies of harmful algal blooms, 
specifically those generated by cyanobacteria, 
have been conducted at freshwater sites. In 
the United States, freshwater harmful algal 
blooms have been associated with waterborne 
disease outbreaks that include dermatologic, 
gastrointestinal, respiratory, febrile, ear, and 
eye symptoms (Dziuban et al. 2006; Hilborn 
et al. 2014; Yoder et al. 2004). The World 
Health Organization (WHO) has established 
guidelines for cell count categories associated 
with the risk of human health effects (Bartram 
and Chorus 1999). The lowest guidance level 
of 20,000 cyanobacterial cells per milliliter 
was derived from an epidemiologic study of 
freshwater cyanobacteria exposure (Pilotto 
et al. 1997). Currently, there is no federal 
regulation of cyanobacteria or cyanotoxin 
exposure for recreational waters in the United 
States; however, several state and local govern-
ments have established guidelines for exposure 
based on their own risk assessments or those 
of the WHO (Burch 2008).
Adverse human health outcomes have 
been associated with marine dinoflagellates, 
diatoms, and cyanobacteria (WHO 2003). 
For example, harmful algal blooms produced 
by Karenia brevis, a marine dinoflagellate, 
have been reported to produce brevetoxins 
that are associated with gastrointestinal and 
respiratory illnesses (Backer et al. 2003, 2005; 
Hlavsa et al. 2011; Kirkpatrick et al. 2010). 
Lyngbya majuscula, a benthic marine cyano-
bacterium, is known to produce toxins, such 
as debromoaplysiatoxin and lyngbyatoxin, 
and to cause acute dermal lesions among 
swimmers (Nagai et al. 1996; Osborne et al. 
2001, 2007; Osborne and Shaw 2008; WHO 
2003). The picoplanktonic Synechococcus, a 
cyanobacterium, has been reported to produce 
microcystins, a group of potent hepatotoxic 
cyanotoxins (Carmichael and Li 2006). A 
limited number of epidemiologic studies have 
investigated the effects of harmful marine algal 
exposures, and most of these have focused 
on blooms of K. brevis (Backer et al. 2003; 
Kirkpatrick et al. 2010). As a result, thresh-
olds or concentrations of phytoplankton 
associated with adverse health effects are not 
well-established for marine waters.
Given the association between increasing 
ocean temperatures and increased frequency 
of harmful algal blooms around the world, 
there is a need to understand the impact of 
harmful algal blooms on human health as 
Address correspondence to E.D. Hilborn, U.S. 
Environmental Protection Agency (EPA), Office 
of Research and Development, National Health 
and Environmental Effects Research Laboratory, 
Environmental Public Health Division, 109 T.W. 
Alexander Dr., Mail Code: 58A, Research Triangle 
Park, NC 27709 USA. Telephone: (919) 966-0658. 
Email: Hilborn.E@epa.gov.
We thank Westat Inc. (Rockville, Maryland), 
L. D’Anglada of the Office of Water (U.S. EPA), and 
the National Epidemiological and Environmental 
Assessment of Recreational (NEEAR) Water Study 
Team for field study implementation. We also thank 
M. Aubel and A. Foss of GreenWater Laboratories 
(Palatka, Florida) for technical guidance; B. Bill of the 
National Oceanic and Atmospheric Administration 
(NOAA) (Seattle, Washington) and N. Osborne of the 
University of Exeter (Cornwall, UK) for thoughtful 
review and comments during manuscript preparation; 
and the NEEAR study participants.
Funding was provided by the U.S. EPA.
The views expressed in this manuscript are those of 
the individual authors and do not necessarily reflect 
the views and policies of the U.S. Environmental 
Protection Agency. Mention of trade names or com-
mercial products does not constitute endorsement or 
recommendation for use.
A.D.C. is employed by GreenWater Laboratories, 
Palatka, Florida. The authors declare they have no 
actual or potential competing financial interests.
Rece ived:  4  December  2014;  Accepted: 
14 September 2015; Advance Publication: 
18 September 2015; Final Publication: 1 April 2016.
A Prospective Study of Marine Phytoplankton and Reported Illness Among 
Recreational Beachgoers in Puerto Rico, 2009
Cynthia J. Lin,1,2 Timothy J. Wade,3 Elizabeth A. Sams,3 Alfred P. Dufour,4 Andrew D. Chapman,5 and 
Elizabeth D. Hilborn3
1Oak Ridge Institute for Science and Education (ORISE) Research Participation Program at the U.S. Environmental Protection Agency 
(EPA), Chapel Hill, North Carolina, USA; 2Department of Epidemiology, UNC Gillings School of Global Public Health, Chapel Hill, North 
Carolina, USA; 3Environmental Public Health Division, National Health and Environmental Effects Research Laboratory, Office of 
Research and Development, U.S. EPA, Research Triangle Park, North Carolina, USA; 4Microbial Chemical Environmental Assessment 
Research Division, National Exposure Research Laboratory, Office of Research and Development, U.S. EPA, Cincinnati, Ohio, USA; 
5GreenWater Laboratories, Palatka, Florida, USA
Background: Blooms of marine phytoplankton may adversely affect human health. The potential 
public health impact of low-level exposures is not well established, and few prospective cohort 
studies of recreational exposures to marine phytoplankton have been conducted.
oBjective: We evaluated the association between phytoplankton cell counts and subsequent illness 
among recreational beachgoers.
Methods: We recruited beachgoers at Boquerón Beach, Puerto Rico, during the summer of 2009. 
We conducted interviews at three time points to assess baseline health, water activities, and subse-
quent illness. Daily water samples were quantitatively assayed for phytoplankton cell count. Logistic 
regression models, adjusted for age and sex, were used to assess the association between exposure to 
three categories of phytoplankton concentration and subsequent illness.
results: During 26 study days, 15,726 individuals successfully completed all three interviews. 
Daily total phytoplankton cell counts ranged from 346 to 2,012 cells/mL (median, 712 cells/mL). 
The category with the highest (≥ 75th percentile) total phytoplankton cell count was associated 
with eye irritation [adjusted odds ratio (OR) = 1.30; 95% confidence interval (CI): 1.01, 1.66], rash 
(OR = 1.27; 95% CI: 1.02, 1.57), and earache (OR = 1.25; 95% CI: 0.88, 1.77). In phytoplankton 
group-specific analyses, the category with the highest Cyanobacteria counts was associated with 
respiratory illness (OR = 1.37; 95% CI: 1.12, 1.67), rash (OR = 1.32; 95% CI: 1.05, 1.66), eye 
irritation (OR = 1.25; 95% CI: 0.97, 1.62), and earache (OR = 1.35; 95% CI: 0.95, 1.93).
conclusions: We found associations between recreational exposure to marine phytoplankton 
and reports of eye irritation, respiratory illness, and rash. We also found that associations varied by 
phytoplankton group, with Cyanobacteria having the strongest and most consistent associations.
citation: Lin CJ, Wade TJ, Sams EA, Dufour AP, Chapman AD, Hilborn ED. 2016. A prospec-
tive study of marine phytoplankton and reported illness among recreational beachgoers in Puerto 
Rico, 2009. Environ Health Perspect 124:477–483; http://dx.doi.org/10.1289/ehp.1409558
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climate change progresses (Dale et al. 2006; 
Gingold et al. 2014; Moore et al. 2008; 
Peperzak 2005). The objective of the present 
study was to evaluate the association between 
phytoplankton cell counts and subsequent 
illness among recrea tional beachgoers at a 
tropical marine beach.
Methods
We conducted a prospective study of beach-
goers at Boquerón Beach, Puerto Rico, in 
the summer of 2009. We assessed the rela-
tionship between phytoplankton counts and 
the development of illness after recreational 
exposure. This study was in the context of the 
National Epidemiological and Environmental 
Assessment of Recreational (NEEAR) Water 
Study. A description of the study design, 
objectives, and protocols and a report of the 
associations between fecal indicator organisms 
and swimming-associated illness have been 
published (Wade et al. 2010b).
Site description. Boquerón Beach is 
located on the southwest coast of Puerto Rico 
(Figure 1). It is approximately 1 mile long 
and is located on Boquerón Bay, adjacent to 
the Caribbean Sea.
Interviews. We offered beachgoers 
enrollment in the study at the beach on 
summer weekends and holidays for a total 
of 26 days. Inclusion criteria consisted of 
a) an adult household member > 21 years 
of age; b) completion of three interviews 
(enrollment, beach exit, follow-up); and 
c) no previous participation in the study 
within the prior 28 days. An adult answered 
questions for all other household members 
at the beach. Interviews began at Boquerón 
Beach on 16 May 2009 and concluded on 
2 August 2009.
Participants gave verbal informed consent 
for study participation in their chosen 
language, English or Spanish, and were inter-
viewed by study personnel proficient in the 
language. All study materials were approved 
by the Institutional Review Board of the 
University of North Carolina at Chapel Hill. 
The enrollment interview collected informa-
tion about demographics, baseline health, 
chronic health conditions, and contact infor-
mation for follow-up. The exit interview 
collected information about water exposure 
and other activities in which the participants 
engaged while at the beach that day. Water 
exposure was ascertained with the following 
questions: “Did you immerse your body, 
not necessarily your head, in the water 
today?” “Did you put your face in the water 
or submerge your head in the water today?” 
and “Did you swallow the water?” The tele-
phone interview, conducted 10–12 days later, 
recorded self-reported illness experienced since 
the beach visit. Participants were offered incen-
tives, such as a cooler, a tote bag, or a beach-
related item, to encourage completion of the 
exit interview. A US$25 check was provided to 
each household after the follow-up telephone 
interview was completed.
Health end points. The health end points 
were defined a priori and were similar to 
those previously studied in relation to recre-
ational water quality and health (Colford 
et al. 2007; Prüss 1998; Wade et al. 2010a). 
They included incident cases of gastroin-
testinal (GI) illness, respiratory illness, rash 
(independent of sunburn), earache, and eye 
irritation occurring during the 10- to 12-day 
period between the beach visit and the follow-
up telephone interview. The definitions for 
each illness are shown in Table 1. Signs and 
symptoms of each health end point were 
inquired about separately. For example, the 
following was asked for stomachache: “Have 
you or anyone else had a stomach ache or 
abdominal cramping since the interview at 
Boquerón Beach?” Individual signs/symptoms 
of illness included the following: stomach-
ache; diarrhea; nausea; vomiting; urinary tract 
infection; fever; headache; sore throat; cough; 
cold; runny or stuffy nose; earache, ear infec-
tion, or runny ears; watery eyes; eye infection; 
infected cut; and rash or itchy skin. For each 
question, participants could answer yes or no; 
they also had the option to refuse to answer 
or to say that they did not know.
Water samples. Three fixed transects were 
selected at least 60 m apart to encompass 
the majority of the beach site. Water at sites 
along each transect was repeatedly sampled 
for marine phytoplankton counts and toxins; 
samples were collected from waist depth at 
each location at 1100 hours on each study day 
(Figure 1). All samples were refrigerated or 
placed on ice within 30 min of collection and 
were maintained under refrigeration during 
shipment to GreenWater Laboratories/
CyanoLab (Palatka, Florida) for analysis. 
Water samples were combined into a daily 
composite sample and were quantitatively 
assayed for total and group phytoplankton 
cell counts (cells per milliliter) by an expe-
rienced phycologist who used the counting 
method described in Standard Methods for 
the Examination of Water and Wastewater 
(American Public Health Association 1998). 
The limit of detection using 5-mL samples at 
100× magnification was 0.2 cells/mL. Water 
samples were also analyzed for two cyano-
bacterial toxins, lyngbyatoxin-a and debro-
moaplysiatoxin, using high-performance liquid 
chromatography–mass spectrometry (HPLC-
MS) (Nagai et al. 1996; Osborne et al. 2008). 
These toxins were selected a priori based on the 
characteristics of the site; the limit of detection 
for both toxins was 1.0 ppb. Major phyto-
plankton groups were identified and included 
Cyanobacteria, Dinophyta (dinoflagellates), 
Bacillariophyta (diatoms), and miscellaneous 
other groups and morphotypes.
Statistical analysis. Multivariable logistic 
regression was used to evaluate the association 
between exposure to different categories of 
phytoplankton cell count and incidence of 
reported illness. The outcome was a binary 
indicator for each health end point as defined 
in Table 1. Each outcome was modeled sepa-
rately. Each analysis excluded participants 
who reported having the outcome of interest 
in the 3 days before their beach visit.
Phytoplankton cell count was categorized 
as high (≥ 75th percentile), medium (> 25th 
to < 75th percentile), and low (≤ 25th percen-
tile). The lowest category served as the referent 
in the regression models. Cell counts were 
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Table 1. Definitions and exclusion criteria for outcomes that occurred during the 10- to 12-day period 




Gastrointestinal illness Any of the following: diarrhea (≥ 3 loose stools in a 24-hour 
period); vomiting; nausea and stomachache; nausea or 
stomachache, and interference with regular activities
Gastrointestinal illness 
or vomiting
Rash Rash or itchy skin Rash
Respiratory illness Any 2 of the following: sore throat, cough, runny nose, cold, 
or fever
Sore throat
Earache Earache, ear infection, or runny ears Earache
Eye irritation Eye irritation or infection, watery eye Eye infection
aBaseline conditions occurred within 3 days before the beach visit.
Marine phytoplankton and reported illness
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considered in total and by phytoplankton 
group (e.g., Bacillariophyta, Cyanobacteria, 
Dinophyta). Picocyanophytes, a subgroup 
of Cyanobacteria, were examined separately 
from the Cyanobacteria group because they 
occurred at an order of magnitude higher 
than the other groups. To focus on those 
with recreational water contact, only partici-
pants who reported body immersion were 
included in models of the association between 
 phytoplankton concentration and illness.
Covariates based on information from 
previous studies were considered for inclusion 
in the final model. Using frequency tables 
and chi-square tests, we identified factors 
associated with illness and/or water exposure 
to potential phytoplankton. These factors 
included age, sex, any other chronic illnesses, 
self-reported contact with algae, Enterococcus 
count, and digging in sand. After adjusting 
for different combinations of covariates, the 
association between phytoplankton exposure 
and incidence of reported illness varied by 
less than 0.1. The final model (adjusting for 
age and sex) was based on minimizing the 
Akaike information criterion (AIC) in order 
to balance model parsimony and fit. In sensi-
tivity analyses, we considered other defini-
tions of water exposure: head immersion and 
swallowing water. Duration of time spent in 
the water was evaluated as a potential effect 
measure modifier in stratified analyses.
Results
Respondent characteristics and demo-
graphics. During the 26 study days, we 
included 15,726 individuals from 6,611 
households. This represented 76% of the 
households initially approached and 96% 
of those completing the beach interview. 
There were slightly more female participants 
(55%), and nearly all (> 99%) participants 
self-identified as Hispanic. The average age 
was 30 years (range: < 1 to 92 years); children 
< 12 comprised < 20% of the study popu-
lation. Approximately one quarter of all 
participants reported having a chronic illness: 
13% reported having allergies, 11% reported 
having asthma, 5% reported having a chronic 
GI illness, and 3% reported having a chronic 
skin condition. Women reported more 
chronic illnesses, specifically chronic GI illness 
(6% women; 3% men; χ2 p-value < 0.0001) 
and allergies (14% women; 11% men; χ2 
p-value = 0.0004). Age categories (0–4 years; 
5–11 years; 12–19 years; 20–34 years; 
35–64 years; ≥ 65 years) revealed differences 
in chronic illness (χ2 p-value = 0.0002); 
chronic GI illness increased with age, reports 
of allergies were infrequent among the 
youngest participants (0–4 years), and reports 
of asthma were most frequent among children 
< 12 years of age. Participants were excluded 
from analyses if they reported having the 
illness being evaluated in the 3 days before 
their beach visit. At enrollment, 8% of partici-
pants reported having a sore throat, and < 3% 
reported vomiting, other GI illness, rash, eye 
irritation, or earache in the previous 3 days. 
Table 2 summarizes the basic characteristics 
for all study participants and for those who 
reported body immersion in the water.
Beach visit activities. Upon leaving the 
beach, 77% of all participants reported body 
immersion in the water, 64% reported head 
immersion, and 36% reported getting water in 
their mouths. Table 3 summarizes a sample of 
activities that participants reported engaging in 
at the beach. We analyzed the 12,111 partici-
pants (77%) who reported at least immersing 
their bodies in the water to improve the 
accuracy of exposure classification based on 
cell counts. As part of a sensitivity analysis, 
more substantial exposures were considered, 
including those who reported swallowing water 
as a marker of extreme exposure (n = 5,615). 
Among participants with body immersion, 
the mean duration spent in the water was just 
> 2 hr. One quarter of all participants spent 
≥ 3 hr in the water, and the maximum time 
spent in the water was 8 hr.
Illness after beach visit. During the 10- to 
12-day period between the beach visit and 
the follow-up telephone interview, respiratory 
illness was most commonly reported, with an 
overall incidence of 7%. The incidence was 
Table 2. Characteristics of study population by level of water contact.
Characteristic
n (%) of all participants 
(n = 15,726)
n (%) of participants reporting 
body immersion (n = 12,111)
Sex
Male 7,052 (44.8) 5,664 (46.8)
Female 8,654 (55.0) 6,431 (53.1)
Missing 20 (0.1) 16 (0.1)
Age category (years)
0–4 908 (5.8) 764 (6.3)
5–11 1,791 (11.4) 1,678 (13.9)
12–19 2,272 (14.5) 1,940 (16.0)
20–34 4,407 (28.0) 3,422 (28.3)
35–64 5,594 (35.6) 3,866 (31.9)
≥ 65 540 (3.4) 284 (2.3)
Missing 214 (1.4) 157 (1.3)
Ethnicity
Non-Hispanic 104 (0.7) 75 (0.6)
Hispanic 15,609 (99.3) 12,027 (99.3)
Missing 13 (0.1) 9 (0.1)
Visits to this beach each summer
0–1 4,592 (29.2) 3,507 (29.0)
2–5 7,533 (47.9) 5,841 (48.2)
> 5 3,600 (22.9) 2,762 (22.8)
Missing 1 (0) 1 (0)
Miles traveled to beach
0–20 5,161 (32.8) 3,878 (32.0)
20–60 5,597 (35.6) 4,339 (35.8)
60–100 2,795 (17.8) 2,162 (17.9)
> 100 1,106 (7.0) 863 (7.1)
Missing 1,067 (6.8) 869 (7.2)
Baseline health in the 3 days prior to beach visit
Vomiting 130 (0.8) 97 (0.8)
Other gastrointestinal illness 309 (2.0) 232 (1.9)
Sore throat 1,263 (8.0) 951 (7.9)
Rash 350 (2.2) 254 (2.1)
Eye irritation 153 (1.0) 98 (0.8)
Earache 224 (1.4) 164 (1.4)
Chronic illness
Any (gastrointestinal, skin, respiratory) 3,878 (24.7) 2,992 (24.7)
Chronic gastrointestinal illness 756 (4.8) 545 (4.5)
Chronic skin condition 548 (3.5) 401 (3.3)
Allergies 2,010 (12.8) 1,540 (12.7)
Asthma 1,684 (10.7) 1,352 (11.2)




No water contact 2,995 (19.0)
Total time spent in water
< 60 min 5,547 (35.3)
60 to < 120 min 3,445 (21.9)
120 to < 180 min 2,835 (18.0)
≥ 180 min 3,892 (24.7)
Body immersion 12,111 (77.0)
Head immersion 10,074 (64.1)
Water in mouth 5,615 (35.7)
Played with algae/seaweed 2,499 (15.9)
Any contact with unknown animals 646 (4.1)
Dug in sand 3,699 (23.5)
Lin et al.
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5% for GI illness, 5% for rash, 3% for eye 
irritation, and 2% for earache.
Water quality. During the 26 study 
days, the median phytoplankton cell 
count was 712 cells/mL per day (range, 
346–2,012 cells/mL). Of all groups identi-
fied, Bacillariophyta had the highest median 
(386 cells/mL per day). Cyanobacteria 
(excluding Picocyanophytes) had a median 
of 132 cells/mL per day. Picocyanophytes 
were only detected on 8 days but achieved 
a maximum count of 126,891 cells/mL. 
Dinophyta had a low median (37 cells/mL 
per day). Samples below the limit of detec-
tion (< 0.2 cells/mL) were assigned a value 
of 0 for calculating phytoplankton distribu-
tions. Table 4 summarizes the phytoplankton 
 distribution over the study period.
Other phytoplankton groups were 
detected on < 8 study days at very low cell 
counts. These groups included Haptophyta 
(mean  = 8.6 cel ls/mL), Chrysophyta 
(mean  = 2.8 cel l s/mL),  Rhodophyta 
(mean = 0.7 cells/mL), Euglenophyta 
(mean = 0.2 cells/mL), and Chlorophyta 
(mean = 0.1 cells/mL). See Appendix 1 for a 
list of the genera and morphotypes that were 
identified and their distribution according 
to phytoplankton group. Concentrations of 
lyngbyatoxin-a and debromoaplysiatoxin were 
below the limit of detection of 1.0 ppb in 
every sample.
Enterococcus colony forming units (CFU) 
and phytoplankton counts were not corre-
lated (Spearman’s r = –0.14, p-value = 0.5). 
As previously reported by Wade et al. 
(2010b), low to moderate levels of fecal 
indicator bacteria were detected at Boquerón 
Beach, and the geometric means of the daily 
samples collected were all below the U.S. 
Environmental Protection Agency (EPA) 
guideline value of 35 CFU per 100 mL (Wade 
et al. 2010b). Spearman’s correlations between 
total phytoplankton counts and different 
environmental factors (e.g., wind speed and 
direction, air temperature, water temperature, 
turbidity) were all < 0.3 (data not shown).
Phytoplankton count and incident illness. 
Among beachgoers who reported body 
immersion, the highest category of total 
phytoplankton cell count (≥ 75th percentile) 
was associated with eye irritation [adjusted 
odds ratio (OR) = 1.30; 95% confidence 
interval (CI): 1.01, 1.66], rash (OR = 1.27; 
95% CI: 1.02, 1.57), and earache (OR = 1.25; 
95% CI: 0.88, 1.77) (Table 5). Cyanobacteria 
cell counts were associated with respiratory 
illness, eye irritation, rash, and earache. These 
associations, although not all statistically 
significant at α = 0.05, strengthened with 
increasing Cyanobacteria cell count categories 
(Figure 2). In particular, respiratory illness, 
rash, and earache all had associations that 
increased relatively monotonically with each 
Cyanobacteria cell count category. Respiratory 
illness had the strongest association with all 
Cyanobacteria cell count categories. Table 5 
shows the associations between phytoplankton 
group cell count and incident illness among 
beachgoers who reported body immersion.
Picocyanophytes were not associated 
with any subsequent illness among partici-
pants who reported body immersion in the 
water (Table 5). However, among those who 
reported swallowing water (n = 5,615), the 
presence of Picocyanophytes was significantly 
associated with earache (OR = 1.62; 95% CI: 
1.14, 2.30), which was reported by 3.3% 
(n = 56) of those exposed and 2.1% (n = 83) 
of those unexposed. Similarly, among partici-
pants who reported swallowing water, the 
highest category of Cyanobacteria cell count 
was associated with earache (OR = 1.75; 
95% CI: 1.09, 2.82), which was reported by 
Table 4. Phytoplankton distribution over 26 days.
Phytoplankton

















All groups/phyla combined 26 (100) 345.7 2011.7 788.9 381.3 581.6 711.6 783.4
Bacillariophyta 26 (100) 128.6 619.4 377.5 102.6 301.2 385.9 442.5
Cyanobacteria (excluding Picocyanophytes) 24 (92) 0 1460.8 254.4 379.4 36.7 131.6 237.4
Picocyanophytes 8 (31) 0 126891.2 22606.4 38020.8 0 0 45126.8
Dinophyta 26 (100) 0.2 105.9 38.9 28.3 23.5 36.6 54.6
Samples below the limit of detection (< 0.2 cells/mL) were assigned a value of 0.
Table 5. Associations between phytoplankton cell counts and incident illness occurring during the 10- to 12-day period between the beach visit and the 












Cases (%) OR (95% CI) Cases (%) OR (95% CI) Cases (%) OR (95% CI) Cases (%) OR (95% CI) Cases (%) OR (95% CI)
All groups combined
≤ Q1 174 (5.0) 1 227 (6.9) 1 114 (3.2) 1 156 (4.5) 1 57 (1.6) 1
> Q1 to < Q3 211 (4.5) 0.91 (0.74, 1.12) 315 (7.1) 1.03 (0.86, 1.23) 144 (3.0) 0.93 (0.72, 1.19) 199 (4.2) 0.95 (0.77, 1.18) 96 (2.0) 1.25 (0.90, 1.74)
≥ Q3 178 (4.9) 1.00 (0.80, 1.24) 244 (7.1) 1.02 (0.85, 1.24) 155 (4.2) 1.30 (1.01, 1.66) 206 (5.6) 1.27 (1.02, 1.57) 76 (2.1) 1.25 (0.88, 1.77)
Bacillariophyta
≤ Q1 142 (4.4) 1 189 (6.1) 1 110 (3.3) 1 170 (5.2) 1 54 (1.6) 1
> Q1 to < Q3 281 (5.0) 1.13 (0.92, 1.39) 405 (7.7) 1.28 (1.07, 1.54) 223 (3.9) 1.18 (0.94, 1.49) 279 (5.0) 0.97 (0.80, 1.18) 118 (2.1) 1.29 (0.93, 1.79)
≥ Q3 140 (4.7) 1.06 (0.83, 1.35) 192 (6.8) 1.10 (0.89, 1.35) 80 (2.7) 0.78 (0.58, 1.05) 112 (3.8) 0.73 (0.57, 0.94) 57 (1.9) 1.15 (0.79, 1.68)
Cyanobacteria
≤ Q1 173 (5.0) 1 187 (5.8) 1 114 (3.3) 1 144 (4.2) 1 55 (1.6) 1
> Q1 to < Q3 226 (4.4) 0.87 (0.71, 1.06) 354 (7.4) 1.30 (1.08, 1.56) 161 (3.1) 0.96 (0.75, 1.22) 236 (4.6) 1.12 (0.90, 1.39) 101 (2.0) 1.25 (0.89, 1.74)
≥ Q3 164 (5.0) 0.98 (0.79, 1.22) 245 (7.8) 1.37 (1.12, 1.67) 138 (4.1) 1.25 (0.97, 1.62) 181 (5.5) 1.32 (1.05, 1.66) 73 (2.2) 1.35 (0.95, 1.93)
Picocyanophytes
None 397 (4.8) 1 527 (6.7) 1 281 (3.3) 1 407 (4.9) 1 155 (1.8) 1
Any 166 (4.7) 0.96 (0.80, 1.16) 259 (7.8) 1.13 (0.97, 1.32) 132 (3.7) 1.10 (0.89, 1.36) 154 (4.3) 0.90 (0.74, 1.09) 74 (2.1) 1.11 (0.83, 1.47)
Dinophyta
≤ Q1 128 (4.5) 1 192 (7.2) 1 96 (3.3) 1 151 (5.3) 1 64 (2.2) 1
> Q1 to < Q3 275 (5.3) 1.22 (0.98, 1.51) 358 (7.2) 1.01 (0.84, 1.21) 185 (3.5) 1.04 (0.81, 1.33) 243 (4.6) 0.84 (0.68, 1.04) 87 (1.6) 0.72 (0.52, 1.01)
≥ Q3 160 (4.3) 0.97 (0.76, 1.23) 236 (6.7) 0.95 (0.78, 1.15) 132 (3.5) 1.05 (0.80, 1.37) 167 (4.4) 0.82 (0.65, 1.03) 78 (2.1) 0.93 (0.67, 1.30)
Abbreviations: CI, confidence interval; OR, adjusted odds ratio; Q1, 25th percentile; Q3, 75th percentile. Models adjusted for age (as a continuous variable) and sex. Denominator for the 
case percentage is the total number in the exposure group.
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3.2% (n = 52) of those exposed to the highest 
category and 1.8% (n = 29) of those exposed 
to the lowest category.
As shown in Table 5, the medium 
category of Bacillariophyta was associated 
with respiratory illness (OR = 1.28; 95% CI 
1.07, 1.54); however, the odds ratio did not 
increase for the highest category (OR = 1.10; 
95% CI: 0.89, 1.35). Exposure to Dinophyta 
was not associated with any illness.
To assess potential effect measure modi-
fication by the length of time spent in water, 
we conducted analyses stratified by number of 
hours spent in the water (< 1 hr, 1 to < 2 hr, 
2 to < 3 hr, ≥ 3 hr). We also restricted our 
analysis to other categories of water exposure 
(head immersion, swallowing water). The 
results were similar in the stratified analyses, 
with the exception of a stronger earache associ-
ation with Cyanobacteria and Picocyanophytes 
after restricting to participants who reported 
swallowing water (data not shown).
Discussion
We report the results of a prospective evalu-
ation of the health effects associated with 
recreational water exposure to marine phyto-
plankton in the absence of a harmful algal 
bloom. Given the popularity of visiting 
beaches (Leeworthy et al. 2005) and the 
apparent increase in harmful algal blooms 
around the world (Sellner et al. 2003), we 
sought to better understand the effects of 
marine phytoplankton on human health. We 
found an association between total phyto-
plankton cell count and incident illness: 
specifically, eye irritation and rash. These 
outcomes have also been associated with 
freshwater blooms (Billings 1981; Pilotto et al. 
1997; Rapala et al. 2005; Walker et al. 2008).
Our study design established a temporal 
sequence between exposure and outcome. By 
having interviews performed at different time 
points, participants did not have to wait a 
long time to recall their experiences, and their 
exposure response could not be influenced by 
any subsequent illness. The high participation 
rate (> 75%) reduced the possibility of selec-
tion bias. After considering a range of poten-
tial confounders, we only adjusted for age 
(as a continuous variable) and sex in order to 
balance model parsimony and fit. Because our 
final model produced similar results to those 
of the full model (adjusting for age, sex, any 
other chronic illnesses, self-reported contact 
with algae, Enterococcus count, and digging in 
sand), there did not appear to be a major bias 
due to confounding (data not shown).
Our study design allowed one adult to 
answer questions for all other household 
members at the beach. Although there was a 
possibility for responder bias or misinforma-
tion, there was an average of only 3.2 indi-
viduals per household, and other household 
members often assisted with the questionnaire 
responses. A limitation of our self-reported 
outcome data was a lack of specific details 
about some of the illnesses. Therefore, it was 
difficult to confirm the etiology of the illness 
on the basis of the participant responses 
alone. For example, we could not necessarily 
distinguish among rashes as being associated 
with cnidarians, sea lice, cercariae, salt water 
itself, or even something completely unrelated 
to the beach visit.
Cyanobacteria concentration was asso-
ciated with all illnesses except GI illness; 
the odds of illness increased with cell count 
category. Our findings were consistent with 
reports of skin and eye irritations associated 
with Lyngbya majuscula blooms (Osborne et al. 
2007; Osborne and Shaw 2008). Despite these 
similar illnesses, the Lyngbya-associated toxins, 
debromoaplysia toxin and lyngbyatoxin-a, were 
below the limit of detection in all samples, 
and Lyngbya comprised only 3% of total 
planktonic Cyanobacteria among samples 
(see Appendix 1). Debromoaplysiatoxin and 
lyngbyatoxin-a are photolabile and are unlikely 
to persist in the water column (Moikeha et al. 
1971). It is possible that people had contact 
with toxins or toxic material in the water or 
on the ocean floor because we did not sample 
the seabed or measure other cyanotoxins 
 potentially associated with Cyanobacteria.
Unlike previous epidemiologic studies of 
freshwater cyanobacterial blooms (Lévesque 
et al. 2014; Pilotto et al. 1997), GI illness 
was the only illness that did not appear to be 
associated with marine Cyanobacteria in the 
absence of blooms, even when we restricted 
the analysis to participants who reported swal-
lowing water. Although the lack of association 
with GI illness may have been because of low 
Cyanobacteria cell counts, health effects may 
also differ after exposure to communities of 
Cyanobacteria in fresh and marine waters. The 
maximum Cyanobacteria cell count (excluding 
Picocyanophytes) was 1460.8 cells/mL. In 
epidemiologic studies conducted at freshwater 
sites, illnesses were associated with cyanobac-
terial counts > 5,000 cells/mL (Pilotto et al. 
1997) and at counts < 20,000 cells/mL relative 
to no water contact (Lévesque et al. 2014). 
More work is needed to define Cyanobacteria 
concentrations that are safe for human health 
in marine waters.
We analyzed Picocyanophytes separately 
because of the different orders of magnitude 
of the cell counts. Although most of the 
cyano bacteria literature describes marine 
picoplankton as nontoxic, there are some 
reports of toxic effects caused by homog-
enized Synechococcus and Synechocystis and their 
extracts (Martins et al. 2005, 2007; Walsh 
et al. 2008). Microcystins have been shown to 
cause adverse health effects (Codd et al. 1999; 
Falconer 1999; Giannuzzi et al. 2011), and a 
study of Synechococcus strains suggested that 
some marine picoplankton may be capable 
of synthesizing microcystins (Carmichael 
and Li 2006).
We observed an association between 
earache and Cyanobacteria among those who 
reported swallowing water. This finding is 
consistent with the positive but nonsignificant 
association we estimated among all those who 
immersed themselves in water. In the context 
of earache, we hypothesize that the stronger 
association, when restricted to those who 
swallowed water, may reflect more frequent 
head immersion and more intense exposure 
overall rather than being a direct consequence 
of swallowing water. Earache has been asso-
ciated with swimming, especially when the 
head is immersed (Wade et al. 2013). The 
Figure 2. Associations between Cyanobacteria cell count and illness among beachgoers who reported 
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presence of any Picocyanophytes (vs. none 
detected) was associated with earache among 
participants who reported swallowing water. 
To our knowledge, this association has not 
been previously reported.
Associations with specific outcomes 
varied among other phytoplankton groups. 
Bacillariophyta cell counts in the 25th to 
75th percentile range, but not counts above 
the 75th percentile, were significantly associ-
ated with respiratory illness when compared 
with counts below the 25th percentile. To 
our knowledge, Bacillariophyta have not been 
associated with respiratory illness in previous 
studies. Previous studies of marine diatoms, 
such as those of the genus Pseudo-nitzschia 
that produce domoic acid, have focused on 
adverse outcomes occurring after ingestion of 
contaminated shellfish rather than on recre-
ational water exposure (Van Dolah 2000).
Because phytoplankton cell counts were 
low, we cannot be confident that associations 
with health outcomes were a result of phyto-
plankton exposure alone, or if phytoplankton 
were markers for other unmeasured caus-
ative factors, such as potentially pathogenic 
microbes or physical-chemical conditions 
associated with marine phytoplankton. In 
addition, we are unable to rule out noncausal 
mechanisms related to chance or bias (e.g., 
uncontrolled confounding, selection bias, 
information bias). Although phytoplankton 
may provide nutrients and substrates for the 
survival of microbial communities, there 
is limited knowledge on the occurrence of 
phytoplankton-associated pathogens (Brettar 
et al. 2007; Maugeri et al. 2004).
We categorized cell count a priori as 
high (≥ 75th percentile), medium (> 25th to 
< 75th percentile), and low (≤ 25th percen-
tile) because health guidelines for concentra-
tions of marine phytoplankton have yet to 
be established. As a result, it is possible that 
the highest cell count category was actually 
below any level that could cause potential 
adverse health effects. For example, although 
we did not find an association of illness 
with Dinophyta, maximum cell counts for 
Dinophyta were only 105.9 cells/mL. In 
contrast, epidemiologic studies of the marine 
dinoflagellate, K. brevis, and associated 
respiratory illness measured maximum cell 
counts ranging from 8,120 cells/mL (Backer 
et al. 2003) to 121,000 cells/mL (Backer 
et al. 2005).
We reported cell counts per milliliter of 
water so that our findings could be compared 
with those of previous studies and the WHO 
guidelines for freshwater exposures (Bartram 
and Chorus 1999). A limitation of our phyto-
plankton assessment was that we had no 
information on cell size to calculate biomass 
concentrations. Cell size can influence total 
phytoplankton exposure. For example, a few 
large cells of one species may contribute more 
to the overall biomass than many small cells 
of a different species (Hillebrand et al. 1999).
Finally, our study participants spent a 
large amount of time in the water; half of 
them spent ≥ 2 hr in the water. It is possible 
that we observed associations between health 
outcomes and low phytoplankton counts, in 
the absence of active phytoplankton blooms, 
because the participants spent so much time 
in the water. However, the associations did 
not vary significantly when stratified by total 
time in the water (data not shown).
Our results offer insight into the potential 
health effects of marine phytoplankton in the 
absence of a harmful algal bloom. Although 
some associations could be due to chance or 
bias, most seem plausible based on the existing 
literature. The evaluation of health effects asso-
ciated with recreational exposure to marine 
phytoplankton at sub-bloom concentrations 
warrants further investigation.
Conclusions
We found associations between recreational 
exposure to marine phytoplankton and subse-
quent reports of eye irritation, respiratory 
illness, earache, and rash at a tropical beach 
in the absence of an algal bloom. In addition, 
we found that associations varied by phyto-
plankton group, with Cyanobacteria having 
the strongest associations with most of the 
outcomes assessed.
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